MENU
NMRA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neumora Therapeutics (NMRA) Ownership - Who owns Neumora Therapeutics?

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed... Show more

Profile

Industry
N/A
Address
490 Arsenal Way
Phone
+1 857 760-0900
Employees
124
Web
https://www.neumoratx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
447.8M
P/E Ratio
N/A
Total Cash
217.59M
Projected Growth
N/A
Total Debt
19.96M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.30
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

NMRA
Capitalization
448M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
218M
Total Cash/Share
1.30
Total Debt
20M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
183M
P/B Ratio
3.39
Cash Flow
N/A
Earnings
-1.57
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16K
Current Ratio
10.54
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-264.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-80.25
Shares Held By Institutions
53.6M
Shares Outstanding - Current
167M
Total Liabilities
40.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-74.623
View a ticker or compare two or three
NMRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
490 Arsenal Way
Phone
+1 857 760-0900
Employees
124
Web
https://www.neumoratx.com